| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |